S&P 500   4,584.12 (+0.37%)
DOW   36,217.89 (+0.26%)
QQQ   390.03 (+0.71%)
AAPL   194.15 (+0.38%)
MSFT   374.71 (+0.59%)
META   320.70 (+0.76%)
GOOGL   131.65 (+0.50%)
AMZN   147.90 (+0.69%)
TSLA   243.03 (+1.81%)
NVDA   471.75 (+1.31%)
NIO   7.64 (+2.83%)
BABA   72.47 (+0.12%)
AMD   120.23 (+1.56%)
T   17.21 (-0.06%)
F   10.69 (+0.85%)
MU   74.75 (+1.44%)
CGC   0.71 (+6.12%)
GE   120.73 (+0.42%)
DIS   91.48 (+0.76%)
AMC   7.09 (+1.00%)
PFE   29.14 (+0.17%)
PYPL   57.81 (-0.19%)
XOM   100.17 (-0.27%)
S&P 500   4,584.12 (+0.37%)
DOW   36,217.89 (+0.26%)
QQQ   390.03 (+0.71%)
AAPL   194.15 (+0.38%)
MSFT   374.71 (+0.59%)
META   320.70 (+0.76%)
GOOGL   131.65 (+0.50%)
AMZN   147.90 (+0.69%)
TSLA   243.03 (+1.81%)
NVDA   471.75 (+1.31%)
NIO   7.64 (+2.83%)
BABA   72.47 (+0.12%)
AMD   120.23 (+1.56%)
T   17.21 (-0.06%)
F   10.69 (+0.85%)
MU   74.75 (+1.44%)
CGC   0.71 (+6.12%)
GE   120.73 (+0.42%)
DIS   91.48 (+0.76%)
AMC   7.09 (+1.00%)
PFE   29.14 (+0.17%)
PYPL   57.81 (-0.19%)
XOM   100.17 (-0.27%)
S&P 500   4,584.12 (+0.37%)
DOW   36,217.89 (+0.26%)
QQQ   390.03 (+0.71%)
AAPL   194.15 (+0.38%)
MSFT   374.71 (+0.59%)
META   320.70 (+0.76%)
GOOGL   131.65 (+0.50%)
AMZN   147.90 (+0.69%)
TSLA   243.03 (+1.81%)
NVDA   471.75 (+1.31%)
NIO   7.64 (+2.83%)
BABA   72.47 (+0.12%)
AMD   120.23 (+1.56%)
T   17.21 (-0.06%)
F   10.69 (+0.85%)
MU   74.75 (+1.44%)
CGC   0.71 (+6.12%)
GE   120.73 (+0.42%)
DIS   91.48 (+0.76%)
AMC   7.09 (+1.00%)
PFE   29.14 (+0.17%)
PYPL   57.81 (-0.19%)
XOM   100.17 (-0.27%)
S&P 500   4,584.12 (+0.37%)
DOW   36,217.89 (+0.26%)
QQQ   390.03 (+0.71%)
AAPL   194.15 (+0.38%)
MSFT   374.71 (+0.59%)
META   320.70 (+0.76%)
GOOGL   131.65 (+0.50%)
AMZN   147.90 (+0.69%)
TSLA   243.03 (+1.81%)
NVDA   471.75 (+1.31%)
NIO   7.64 (+2.83%)
BABA   72.47 (+0.12%)
AMD   120.23 (+1.56%)
T   17.21 (-0.06%)
F   10.69 (+0.85%)
MU   74.75 (+1.44%)
CGC   0.71 (+6.12%)
GE   120.73 (+0.42%)
DIS   91.48 (+0.76%)
AMC   7.09 (+1.00%)
PFE   29.14 (+0.17%)
PYPL   57.81 (-0.19%)
XOM   100.17 (-0.27%)

Fortrea Stock Price, News & Analysis (NASDAQ:FTRE)

$30.94
-0.70 (-2.21%)
(As of 12/5/2023 ET)
Compare
Today's Range
$30.70
$31.46
50-Day Range
$27.12
$33.55
52-Week Range
$24.92
$37.30
Volume
531,961 shs
Average Volume
1.73 million shs
Market Capitalization
$2.75 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.25

FTRE stock logo

About Fortrea Stock (NASDAQ:FTRE)

Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina.

FTRE Stock Price History

FTRE Stock News Headlines

Evercore ISI Upgrades Fortrea (NASDAQ:FTRE) to Outperform
Fortrea (NASDAQ:FTRE) Shares Gap Up to $29.44
Energy Storage Trend Ignites Frenzy Over Vanadium Supply
As the world shifts to renewables such as wind and solar, how will we store all this energy? Vanadium batteries are the breakthrough that some experts predict will be the future of grid-scale energy storage. The problem is, only 5% of vanadium is mined in the U.S. - and China and Russia have a stranglehold on our supply.
The Latest Analyst Ratings for Fortrea Holdings
Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today?
Fortrea upgraded at Barclays after Q3 beat
Fortrea Holdings Q3 Earnings: A Very Mixed Bag
Energy Storage Trend Ignites Frenzy Over Vanadium Supply
As the world shifts to renewables such as wind and solar, how will we store all this energy? Vanadium batteries are the breakthrough that some experts predict will be the future of grid-scale energy storage. The problem is, only 5% of vanadium is mined in the U.S. - and China and Russia have a stranglehold on our supply.
Fortrea Reports Third Quarter 2023 Results
Fortrea Holdings Inc FTRE
Why Fortrea Holdings Shares Are Gaining Today
Here’s Why Vltava Fund Sold Fortrea Holdings (FTRE)
See More Headlines
Receive FTRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
12/05/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/12/2024

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FTRE
Fax
N/A
Employees
19,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$33.25
High Stock Price Target
$38.00
Low Stock Price Target
$27.00
Potential Upside/Downside
+7.5%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.75 billion
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Ms. Jill McConnell (Age 49)
    Chief Financial Officer
    Comp: $615.13k
  • Mr. Mark A. Morais (Age 47)
    COO & President of Clinical Services
    Comp: $537.45k
  • Mr. Thomas H. PikeMr. Thomas H. Pike (Age 64)
    CEO, President & Chairman
  • Ms. Hima B. Inguva
    Head of Investor Relations & Corporate Development
  • Dr. John J. Doyle
    President of Consulting














FTRE Stock Analysis - Frequently Asked Questions

Should I buy or sell Fortrea stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fortrea in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" FTRE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FTRE, but not buy additional shares or sell existing shares.
View FTRE analyst ratings
or view top-rated stocks.

What is Fortrea's stock price target for 2024?

4 brokerages have issued 1-year price targets for Fortrea's shares. Their FTRE share price targets range from $27.00 to $38.00. On average, they predict the company's share price to reach $33.25 in the next twelve months. This suggests a possible upside of 7.5% from the stock's current price.
View analysts price targets for FTRE
or view top-rated stocks among Wall Street analysts.

How have FTRE shares performed in 2023?

Fortrea's stock was trading at $32.52 at the beginning of 2023. Since then, FTRE stock has decreased by 4.9% and is now trading at $30.94.
View the best growth stocks for 2023 here
.

When is Fortrea's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 12th 2024.
View our FTRE earnings forecast
.

How were Fortrea's earnings last quarter?

Fortrea Holdings Inc. (NASDAQ:FTRE) issued its quarterly earnings results on Monday, November, 13th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.08. The firm earned $776.40 million during the quarter, compared to analyst estimates of $748.90 million. The company's quarterly revenue was up 1.8% compared to the same quarter last year.

How do I buy shares of Fortrea?

Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:FTRE) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -